These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6360773)

  • 1. Effect of cicloxilic acid on bile lipid composition in patients with gallstones: a multicenter trial.
    Carulli N; Ponz de Leon M; Podda M; Di Padova C; Zuin M
    Digestion; 1983; 28(2):102-7. PubMed ID: 6360773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cicloxilic acid on the bile lipid composition in cholelithiasis.
    Carulli N; Ferenderes R; Ponz De Leon M
    Arzneimittelforschung; 1978; 28(7a):1240-2. PubMed ID: 582964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cicloxilic acid on bile flow and biliary lipid secretion in humans.
    Di Padova C; Tritapepe R; Di Padova F; Pozzoli M
    Am J Gastroenterol; 1984 Sep; 79(9):715-7. PubMed ID: 6475902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3-hydroxy-3-methylglutaric acid administration on bile lipid composition in humans.
    Di Padova C; Di Padova F; Buzzetti M; Tritapepe R
    Scand J Gastroenterol; 1984 Sep; 19(6):820-3. PubMed ID: 6083597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile lipid output and composition in patients fitted with external biliary drainage: activity of cicloxilic acid.
    Tommasini Degna C; Rossetti O; Vizzotto L
    Curr Med Res Opin; 1983; 8(7):472-4. PubMed ID: 6627972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study.
    Hofmann AF; Grundy SM; Lachin JM; Lan SP; Baum RA; Hanson RF; Hersh T; Hightower NC; Marks JW; Mekhjian H; Shaefer RA; Soloway RD; Thistle JL; Thomas FB; Tyor MP
    Gastroenterology; 1982 Oct; 83(4):738-52. PubMed ID: 7106505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cicloxilic acid on biliary lipid output in man.
    Sama C; Festi D; Aldini R; Mazzella C; Roda A; Bazzoli F; Roda E
    Farmaco Prat; 1978 Aug; 33(8):371-8. PubMed ID: 748062
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cicloxilic acid on biliary dynamics].
    Tacla M; Pontes JF
    Arq Gastroenterol; 1980; 17(4):203-9. PubMed ID: 7247747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dihydroxydibutylether on bile lipid composition in patients with gallstones.
    Ponz de Leon M; Loria P; Iori R; Piccagli I; Carulli N; Belvisi A; Matergi M
    Int J Clin Pharmacol Ther Toxicol; 1983 Jan; 21(1):37-40. PubMed ID: 6832865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects.
    Lee DW; Gilmore CJ; Bonorris G; Cohen H; Marks JW; Cho-Sue M; Meiselman MS; Schoenfield LJ
    Am J Clin Nutr; 1985 Sep; 42(3):414-20. PubMed ID: 4036847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
    Reuben A; Maton PN; Murphy GM; Dowling RH
    Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
    Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
    Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine determination of biliary lipid composition with the entero-test.
    Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
    Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral administration of 'essential' phospholipid, beta-glycerophosphate, and linoleic acid on biliary lipids in patients with cholelithiasis.
    Holan KR; Holzbach RT; Hsieh JY; Welch DK; Turcotte JG
    Digestion; 1979; 19(4):251-8. PubMed ID: 573222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.